# Banco Bilbao Vizcaya Argentaria, S.A.: financial statements, quarterly

BBVA · NYSE · CIK 842180 · [Financials](/sectors/financials.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/bbva.md) · [Financials](/companies/bbva/financials.md) · [Filings](/companies/bbva/filings.md) · [Insiders](/companies/bbva/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/bbva/financials.md?period=annual).

## Balance sheet

| Line item | Unit | period not labelled (2016-12-31) | period not labelled (2017-08-31) | FY2017 (2017-12-31) | period not labelled (2018-08-31) | FY2018 (2018-12-31) | FY2019 (2019-12-31) | FY2020 (2020-12-31) | FY2021 (2021-12-31) | FY2022 (2022-12-31) | FY2023 (2023-12-31) | FY2024 (2024-12-31) | FY2025 (2025-12-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $bn | [40.0](/filings/0000842180-19-000005.md) | [5.1](/filings/0000842180-18-000006.md) | [42.7](/filings/0000842180-20-000006.md) | [4.6](/filings/0000842180-19-000005.md) | [58.2](/filings/0000842180-21-000008.md) | [44.3](/filings/0000842180-22-000011.md) | [76.9](/filings/0000842180-24-000007.md) | [67.8](/filings/0000842180-25-000010.md) | [79.8](/filings/0001628280-26-010001.md) | [75.4](/filings/0001628280-26-010001.md) | [51.1](/filings/0001628280-26-010001.md) | [58.8](/filings/0001628280-26-010001.md) |
| Total assets | $bn | [732](/filings/0000842180-19-000005.md) | not reported | [690](/filings/0000842180-20-000006.md) | not reported | [676](/filings/0000842180-21-000008.md) | [695](/filings/0000842180-22-000011.md) | [734](/filings/0000842180-23-000010.md) | [663](/filings/0000842180-24-000007.md) | [712](/filings/0000842180-25-000010.md) | [776](/filings/0001628280-26-010001.md) | [772](/filings/0001628280-26-010001.md) | [860](/filings/0001628280-26-010001.md) |
| Total liabilities | $bn | [676](/filings/0000842180-19-000005.md) | not reported | [637](/filings/0000842180-20-000006.md) | not reported | [623](/filings/0000842180-21-000008.md) | [641](/filings/0000842180-22-000011.md) | [684](/filings/0000842180-23-000010.md) | [614](/filings/0000842180-24-000007.md) | [662](/filings/0000842180-25-000010.md) | [720](/filings/0001628280-26-010001.md) | [712](/filings/0001628280-26-010001.md) | [798](/filings/0001628280-26-010001.md) |
| Shareholders' equity | $bn | [55.4](/filings/0000842180-19-000005.md) | not reported | [53.3](/filings/0000842180-20-000006.md) | not reported | [52.9](/filings/0000842180-22-000011.md) | [54.9](/filings/0000842180-23-000010.md) | [50.0](/filings/0000842180-23-000010.md) | [48.7](/filings/0000842180-25-000010.md) | [50.5](/filings/0001628280-26-010001.md) | [55.3](/filings/0001628280-26-010001.md) | [60.0](/filings/0001628280-26-010001.md) | [61.8](/filings/0001628280-26-010001.md) |

- Cash and equivalents: ifrs-full:CashAndCashEquivalents
- Total assets: ifrs-full:Assets
- Total liabilities: ifrs-full:Liabilities
- Shareholders' equity: ifrs-full:Equity

Shares outstanding: 5,708,968,700 at 2025-12-31, from the cover of the [20-F filed 2026-02-20](/filings/0001628280-26-010001.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:25 ET. No prices; not investment advice.